Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $14 from $18 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results which provided many updates by low visibility remains.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $13 from $16 at Piper Sandler
- Dentsply Sirona Unveils Strategic Plan Amid Q3 Losses
- DENTSPLY SIRONA Faces Challenges Amid Earnings Call Insights
- Dentsply Sirona downgraded to Market Perform from Outperform at William Blair
- DENTSPLY SIRONA: Hold Rating Amid Strategic Investments and Revised Growth Outlook